CRCAM BRIE PIC2-CCI (CRBP2.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:CRBP2 • FR0010483768

29.8 EUR
0 (0%)
Last: Feb 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

2

Overall CRBP2 gets a fundamental rating of 2 out of 10. We evaluated CRBP2 against 114 industry peers in the Banks industry. CRBP2 has a bad profitability rating. Also its financial health evaluation is rather negative. CRBP2 has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • CRBP2 had positive earnings in the past year.
  • In the past year CRBP2 has reported a negative cash flow from operations.
  • In the past 5 years CRBP2 has always been profitable.
  • The reported operating cash flow has been mixed in the past 5 years: CRBP2 reported negative operating cash flow in multiple years.
CRBP2.PA Yearly Net Income VS EBIT VS OCF VS FCFCRBP2.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

1.2 Ratios

  • CRBP2's Return On Assets of 0.53% is on the low side compared to the rest of the industry. CRBP2 is outperformed by 63.06% of its industry peers.
  • Looking at the Return On Equity, with a value of 3.86%, CRBP2 is doing worse than 75.68% of the companies in the same industry.
Industry RankSector Rank
ROA 0.53%
ROE 3.86%
ROIC N/A
ROA(3y)0.47%
ROA(5y)0.46%
ROE(3y)3.92%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
CRBP2.PA Yearly ROA, ROE, ROICCRBP2.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3 4 5

1.3 Margins

  • Looking at the Profit Margin, with a value of 26.10%, CRBP2 is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • CRBP2's Profit Margin has declined in the last couple of years.
  • The Operating Margin and Gross Margin are not available for CRBP2 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 26.1%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-6.32%
PM growth 5Y-2.49%
GM growth 3YN/A
GM growth 5YN/A
CRBP2.PA Yearly Profit, Operating, Gross MarginsCRBP2.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • CRBP2 does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CRBP2 has been reduced compared to 1 year ago.
  • Compared to 5 years ago, CRBP2 has more shares outstanding
  • Compared to 1 year ago, CRBP2 has an improved debt to assets ratio.
CRBP2.PA Yearly Shares OutstandingCRBP2.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CRBP2.PA Yearly Total Debt VS Total AssetsCRBP2.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

  • A Debt/Equity ratio of 0.20 indicates that CRBP2 is not too dependend on debt financing.
  • CRBP2's Debt to Equity ratio of 0.20 is amongst the best of the industry. CRBP2 outperforms 88.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC6.37%
CRBP2.PA Yearly LT Debt VS Equity VS FCFCRBP2.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CRBP2.PA Yearly Current Assets VS Current LiabilitesCRBP2.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • CRBP2 shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.77%.
  • CRBP2 shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.97% yearly.
  • CRBP2 shows a decrease in Revenue. In the last year, the revenue decreased by -1.48%.
  • CRBP2 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.72% yearly.
EPS 1Y (TTM)7.77%
EPS 3Y-3.01%
EPS 5Y1.97%
EPS Q2Q%14.23%
Revenue 1Y (TTM)-1.48%
Revenue growth 3Y3.81%
Revenue growth 5Y4.72%
Sales Q2Q%-1.45%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CRBP2.PA Yearly Revenue VS EstimatesCRBP2.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 7.41, the valuation of CRBP2 can be described as very cheap.
  • Based on the Price/Earnings ratio, CRBP2 is valued cheaply inside the industry as 91.89% of the companies are valued more expensively.
  • CRBP2 is valuated cheaply when we compare the Price/Earnings ratio to 27.93, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.41
Fwd PE N/A
CRBP2.PA Price Earnings VS Forward Price EarningsCRBP2.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CRBP2.PA Per share dataCRBP2.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200 300

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)3.75
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.86%, CRBP2 has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 4.12, CRBP2 has a dividend in line with its industry peers.
  • CRBP2's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 3.86%

5.2 History

  • The dividend of CRBP2 has a limited annual growth rate of 1.28%.
Dividend Growth(5Y)1.28%
Div Incr Years3
Div Non Decr Years3
CRBP2.PA Yearly Dividends per shareCRBP2.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • The dividend of CRBP2 is growing, but earnings are growing more, so the dividend growth is sustainable.
DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
CRBP2.PA Yearly Income VS Free CF VS DividendCRBP2.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

More info and screens

Find the best dividend stocksShow peers with best dividend

CRCAM BRIE PIC2-CCI

EPA:CRBP2 (2/6/2026, 7:00:00 PM)

29.8

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)01-29
Earnings (Next)04-21
Inst Owners3.5%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap477.10M
Revenue(TTM)837.21M
Net Income(TTM)218.51M
Analysts83.64
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.86%
Yearly Dividend0.71
Dividend Growth(5Y)1.28%
DPN/A
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 7.41
Fwd PE N/A
P/S 0.57
P/FCF N/A
P/OCF N/A
P/B 0.08
P/tB 0.08
EV/EBITDA N/A
EPS(TTM)4.02
EY13.49%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-27.7
FCFYN/A
OCF(TTM)-26.94
OCFYN/A
SpS52.29
BVpS353.77
TBVpS353.75
PEG (NY)N/A
PEG (5Y)3.75
Graham Number178.88
Profitability
Industry RankSector Rank
ROA 0.53%
ROE 3.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 26.1%
GM N/A
FCFM N/A
ROA(3y)0.47%
ROA(5y)0.46%
ROE(3y)3.92%
ROE(5y)3.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-6.32%
PM growth 5Y-2.49%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 59.41%
Cap/Sales 1.46%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC6.37%
ROIC/WACCN/A
Cap/Depr(3y)66.63%
Cap/Depr(5y)90.91%
Cap/Sales(3y)1.62%
Cap/Sales(5y)2.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.77%
EPS 3Y-3.01%
EPS 5Y1.97%
EPS Q2Q%14.23%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.48%
Revenue growth 3Y3.81%
Revenue growth 5Y4.72%
Sales Q2Q%-1.45%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y81.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.29%
OCF growth 3YN/A
OCF growth 5YN/A

CRCAM BRIE PIC2-CCI / CRBP2.PA FAQ

What is the fundamental rating for CRBP2 stock?

ChartMill assigns a fundamental rating of 2 / 10 to CRBP2.PA.


What is the valuation status of CRCAM BRIE PIC2-CCI (CRBP2.PA) stock?

ChartMill assigns a valuation rating of 2 / 10 to CRCAM BRIE PIC2-CCI (CRBP2.PA). This can be considered as Overvalued.


What is the profitability of CRBP2 stock?

CRCAM BRIE PIC2-CCI (CRBP2.PA) has a profitability rating of 2 / 10.


Can you provide the financial health for CRBP2 stock?

The financial health rating of CRCAM BRIE PIC2-CCI (CRBP2.PA) is 2 / 10.